Skip to main content
SpringerLink
Log in

La chirurgie des cancers de l’ovaire : les grands principes encore valides

Surgery for ovarian cancer: Main principles still valid

  • Mise au Point / Update
  • Published:
Oncologie

Résumé

Le cancer de l’ovaire est la première cause de mortalité par cancer gynécologique. La chirurgie est avec la chimiothérapie la base du traitement. La résection complète des lésions est l’objectif de la chirurgie qu’elle soit faite au début du traitement ou après quelques cycles de chimiothérapie. La sélection des patientes entre chirurgie immédiate ou différée est la seule question incomplètement résolue. Les sites qui prennent en charge ces patientes et leur parcours de soins semblent au moins aussi importants que la qualité de l’acte chirurgical proprement dit.

Abstract

Ovarian cancer is the leading cause of mortality by gynecologic cancer. Surgery and chemotherapy are the cornerstones of the treatment. The objective of surgery is complete resection of macroscopic lesions. Surgery can be proposed in an upfront situation or after some cycles of chemotherapy. Selection of patients is the only remaining matter of debate. Hospitals that treat these patients and the patient’s course seem as important as the quality of the surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Projection de l’incidence et de la mortalité par cancer en France en 2011. InVS-INCa. www.e-cancer.fr

  2. Prat J (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet 124: 1–5

    Article  Google Scholar 

  3. Mahdi H, Moslemi-Kebria M, Levinson KL, et al. (2013) Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma. Int J Gynecol Cancer 23: 1226–1230

    Article  PubMed  Google Scholar 

  4. Ghezzi F, Malzoni M, Vizza E, et al. (2012) Laparoscopic staging of early ovarian cancer: results of a multi-institutional cohort study. Ann Surg Oncol 19: 1589–1594

    Article  PubMed  Google Scholar 

  5. Morice P, Denschlag D, Rodolakis A, et al. (2011) Recommendations of the fertility task force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer 21: 951–963

    Article  PubMed  Google Scholar 

  6. Recommandations de Saint-Paul-de-Vence sur le cancer de l’ovaire. www.arcagy.org

  7. Chi DS, Franklin CC, Levine DA, et al. (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94: 650–654

    Article  PubMed  Google Scholar 

  8. http://www.clinicaltrials.gov/show/NCT01218490 (CARACO)

  9. Vergote I, Tropé C, Amant F, et al. (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363: 943–953

    Article  CAS  PubMed  Google Scholar 

  10. Angioli R, Plotti F, Capriglione S, et al. (2013) Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol 128: 579–583

    Article  CAS  PubMed  Google Scholar 

  11. Gouy S, Belghiti J, Uzan C, et al. (2013) Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy. Int J Gynecol Cancer 23: 1699–1703

    Article  PubMed  Google Scholar 

  12. Rose P, Nerenstone S, Brady M, et al. (2004) Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 351: 2489–2497

    Article  CAS  PubMed  Google Scholar 

  13. http://clinicaltrials.gov/show/NCT01739218 (ANTHALYA)

  14. http://clinicaltrials.gov/show/NCT01583322 (CHIVA)

  15. Querleu D, Ray-Coquard I, Classe JM, et al. (2013) Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Société française d’oncologie gynécologique, SFOG). Ann Oncol 24: 2732–2739

    Article  CAS  PubMed  Google Scholar 

  16. Bristow R (2013) The New York Times — http://www.nytimes.com/2013/03/12/health/ovarian-cancer-study-finds-widespreadflaws-in-treatment.html

    Google Scholar 

  17. Rafii A, Stoeckle E, Jean-Laurent M, et al. (2012) Multi-center evaluation of post-operative morbidity and mortality after optimal cytoreductive surgery for advanced ovarian cancer. PLoS One 7: e39415. doi:10.1371/journal.pone.0039415

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Jordan S, Steer C, DeFazio A, et al. (2013) Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer— a population-based study. Gynecol Oncol 129: 310–317

    Article  CAS  PubMed  Google Scholar 

  19. Harter P, du Bois A, Hahmann M, et al. (2006) Surgery in recurrent ovarian cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial. Ann Surg Oncol 13: 1702–1710

    Article  PubMed  Google Scholar 

  20. http://www.clinicaltrials.gov/show/NCT01166737 — DESKTOP III

  21. http://clinicaltrials.gov/show/NCT01376752 (CHIPOR)

Download references

Author information

Authors and Affiliations

  1. Centre expert oncologie gynécologique Paris-Descartes, hôpital européen Georges-Pompidou, AP-HP, Paris, France

    F. Lécuru, A. -S. Bats, C. Bensaid, C. Ngo, N. Douay-Hauser, J. Seror, C. Nos, P. Combe, J. Medioni & E. Pujade-Lauraine

  2. Faculté de médecine, université Paris-Descartes, Sorbonne Paris Cité, Paris, France

    F. Lécuru, A. -S. Bats, C. Bensaid, C. Ngo, N. Douay-Hauser, J. Seror, C. Nos, P. Combe, J. Medioni & E. Pujade-Lauraine

  3. UMR S 747, faculté de médecine, université Paris-Descartes, Paris, France

    F. Lécuru, A. -S. Bats, C. Bensaid, C. Ngo, N. Douay-Hauser, J. Seror, C. Nos, P. Combe, J. Medioni & E. Pujade-Lauraine

  4. GINECO ARCAGY, hôpital Hôtel Dieu, 1, Parvis Notre-Dame, F-75181, Paris cedex 04, France

    F. Lécuru, P. Combe & E. Pujade-Lauraine

Authors
  1. F. Lécuru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. -S. Bats
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Bensaid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Ngo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Douay-Hauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Seror
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Nos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Combe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Medioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. Pujade-Lauraine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Lécuru.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lécuru, F., Bats, A.S., Bensaid, C. et al. La chirurgie des cancers de l’ovaire : les grands principes encore valides. Oncologie 16, 313–316 (2014). https://doi.org/10.1007/s10269-014-2403-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-014-2403-1

Mots clés

Keywords

Search

Navigation